Health values of patients with systemic sclerosis
- PMID: 17266070
- DOI: 10.1002/art.22465
Health values of patients with systemic sclerosis
Abstract
Objective: To assess health values in subjects with systemic sclerosis (SSc) and determine variability explained by demographics, clinical factors, health status, and disease severity.
Methods: We interviewed 107 individuals with SSc who attended national and local Scleroderma Foundation meetings in 2005. Health status was measured using the Short Form 36 (SF-36) Physical Component Summary (PCS; range 0-100) and Mental Component Summary (MCS; range 0-100), the Center for Epidemiologic Studies Depression Scale (CES-D; range 0-60), and the Health Assessment Questionnaire (HAQ) disability index (DI; range 0-3). Disease severity was assessed using a visual analog scale (VAS; range 0-150). Health value measures included the 0-100 health rating scale (RS), standard gamble (SG; range 0.0-1.0), and time trade-off (TTO; range 0.0-1.0). We performed univariate analyses to compare scores between participants with limited cutaneous SSc (lcSSc) and diffuse cutaneous SSc (dcSSc), and multivariable analyses for 3 outcome measures: RS, SG, and TTO, controlling for demographics, type of SSc, health status, and disease severity.
Results: Of the 107 participants, 48 had dcSSc and 59 had lcSSc. Ninety-seven were women and 83 were white. The median scores for the PCS, MCS, and HAQ DI were 36.9, 45.5, and 0.9, respectively. Fifty-five subjects had significant depressive symptoms (CES-D score >or=16). The median RS, SG, and TTO scores were 62, 0.83 (indicating a willingness to accept up to a 17% risk of immediate death in exchange for perfect health), and 0.88 (indicating a willingness to give up a median of 12% of life expectancy in exchange for perfect health), respectively. Subjects with dcSSc had lower RS scores but higher SG scores (corresponding to a willingness to accept only a smaller risk of death) than subjects with lcSSc. TTO scores were similar in the 2 groups. Health values were variably related to factors such as demographics, VAS score, disease classification, and SF-36 PCS and MCS scores (R(2) = 0.22, 0.23, and 0.66 for the SG, TTO, and RS models, respectively).
Conclusion: Individuals with dcSSc have lower health ratings but higher SG health values than individuals with lcSSc. These findings have implications for decision analysis and cost-effectiveness analysis.
Similar articles
-
Psychometric properties of the Swedish version of the Scleroderma Health Assessment Questionnaire and the Cochin Hand Function Scale in patients with systemic sclerosis.Scand J Rheumatol. 2013;42(4):317-24. doi: 10.3109/03009742.2012.756928. Epub 2013 Feb 27. Scand J Rheumatol. 2013. PMID: 23442162
-
Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey.Arthritis Rheum. 2007 Feb 15;57(1):94-102. doi: 10.1002/art.22468. Arthritis Rheum. 2007. PMID: 17266096
-
The minimally important difference in clinical practice for patient-centered outcomes including health assessment questionnaire, fatigue, pain, sleep, global visual analog scale, and SF-36 in scleroderma.J Rheumatol. 2010 Mar;37(3):591-8. doi: 10.3899/jrheum.090375. Epub 2010 Jan 15. J Rheumatol. 2010. PMID: 20080913
-
The impact of systemic sclerosis on health-related quality of life assessed by SF-36: A systematic review and meta-analysis.Int J Rheum Dis. 2018 Nov;21(11):1884-1893. doi: 10.1111/1756-185X.13438. Epub 2018 Nov 14. Int J Rheum Dis. 2018. PMID: 30428506
-
Health-related quality of life in systemic sclerosis before and after autologous haematopoietic stem cell transplant-a systematic review.Rheumatology (Oxford). 2020 Apr 1;59(4):779-789. doi: 10.1093/rheumatology/kez300. Rheumatology (Oxford). 2020. PMID: 31504944
Cited by
-
Quality of life as measured by the short-form 36 (SF-36) questionnaire in patients with early systemic sclerosis and undifferentiated connective tissue disease.Health Qual Life Outcomes. 2013 Feb 25;11:23. doi: 10.1186/1477-7525-11-23. Health Qual Life Outcomes. 2013. PMID: 23442975 Free PMC article.
-
Health State Utilities and Disease Duration in Systemic Sclerosis: Is There an Association?J Rheumatol. 2016 Oct;43(10):1832-1837. doi: 10.3899/jrheum.160162. Epub 2016 Aug 1. J Rheumatol. 2016. PMID: 27481898 Free PMC article.
-
Reliability, validity, and minimally important differences of the SF-6D in systemic sclerosis.Qual Life Res. 2007 Aug;16(6):1083-92. doi: 10.1007/s11136-007-9207-3. Epub 2007 Apr 3. Qual Life Res. 2007. PMID: 17404896 Clinical Trial.
-
Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosis.Rheumatology (Oxford). 2011 Feb;50(2):330-4. doi: 10.1093/rheumatology/keq296. Epub 2010 Sep 30. Rheumatology (Oxford). 2011. PMID: 20884655 Free PMC article.
-
Needs and preferences regarding health care delivery as perceived by patients with systemic sclerosis.Clin Rheumatol. 2011 Jun;30(6):815-24. doi: 10.1007/s10067-010-1645-6. Epub 2011 Jan 18. Clin Rheumatol. 2011. PMID: 21243390 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical